share_log

公告精选 | 中国恒大:极力反对清盘呈请;携程Q1净营收41亿元,同比保持稳定

Selected Announcements | China Evergrande: Strongly Opposes Liquidation Petition; Ctrip's Q1 Net Revenue Was 4.1 Billion Yuan, Stable Year Over Year

富途資訊 ·  Jun 28, 2022 08:24

Selection of blockbuster announcements

1、$Trip.com-S (09961.HK) $The net operating income in the first quarter was 4.1 billion yuan, which remained stable compared with the same period last year.

Trip.com announced the first quarter of 2022 results announcement. In the first quarter of 2022, Trip.com 's net operating income was 4.1 billion yuan, which remained stable compared with the same period last year; the net loss attributable to Trip.com shareholders was 989 million yuan, compared with 1.8 billion yuan net profit attributable to Trip.com shareholders in the same period in 2021.

2、$China Evergrande Group (03333.HK) $Strongly opposes the Top Shine Global winding-up petition

China Evergrande Group announced on the Hong Kong Stock Exchange that Top Shine Global Limited of Intershore Consult (Samoa) Limited filed a winding-up petition against the Company in the High Court of the Hong Kong Special Administrative region on 24 June 2022, involving the financial obligations of the Company of HK $862.5 million. As far as the directors of the company know and believe, the petitioner is represented by Lian Haomin. Our company will strongly object to the petition. The Company expects that the petition will not affect the Company's reorganization plan or timetable. The company has been actively communicating with creditors to promote overseas debt restructuring and is expected to announce a preliminary plan for overseas debt restructuring before the end of July.

3、$clover organism-B (02197.HK) $COVID-19 candidate vaccine showed strong cross-neutralizing effect on Omicron as a homologous strengthening needle.

Clover Biology announces new positive clinical data for individuals inoculated with a third dose SCB-2019 (CpG 1018 ╱ aluminum adjuvant) homologous strengthening needle for the Omicron mutant. When the baseline serum negative subjects were inoculated with SCB-2019 (CpG 1018 ╱ aluminum adjuvant) homologous strengthening needle, the level of neutralizing antibody against Omicron mutant BA.2 was significantly increased by 19 times as compared with that before inoculation.

4. Weilong heard through the Hong Kong Stock Exchange, and its income increased to 4.8 billion yuan in 2021.

According to HKEx documents, Weilong delicious Global Holdings Limited is listed on the Hong Kong Stock Exchange, with Morgan Stanley, China International Capital Corporation and UBS as co-sponsors. The company submitted its form on November 12 last year and passed a hearing on the 15th of that month.

According to data, Weilong is the largest spicy snack food company in China in 2021, with a market share of 6.2%, 3.9 times that of the second largest company in terms of retail sales. In terms of financial data, the company recorded revenue of about 3.385 billion yuan in 2019, 4.12 billion yuan in 2020 and 4.8 billion yuan in 2021, and recorded profits of about 658 million yuan, 819 million yuan and 827 million yuan respectively. Gross profit margin remained relatively stable in 2020 and 2021, 38.0% and 37.4% respectively.

5. MINISO Group was heard by the Hong Kong Stock Exchange, with a paper cash of up to 5.3 billion.

According to HKEx documents, MINISO Group has been listed through the Hong Kong Stock Exchange, with BofA Securities, Haitong International and UBS Securities as co-sponsors and will return to Hong Kong shares in the form of a "dual major listing".

According to MINISO Group's prospectus submitted to the Hong Kong Stock Exchange, MINISO Group's income for the financial years ending June 30, 2019, 2020 and 2021 was 9.395 billion yuan, 8.979 billion yuan and 9.072 billion yuan respectively, and 7.768 billion yuan in the first three quarters of fiscal year 2022, an increase of nearly 18 percent over the first three quarters of fiscal year 2021. Cash flow from operating activities in fiscal year 2019-2021 was RMB 1.04 billion, 830 million and 920 million, respectively, compared with 1.05 billion in the first three quarters of fiscal year 2022.

6. Emick submitted an application for listing of Hong Kong shares

According to HKEx filings, Aimeke Technology Development Co., Ltd. submitted an application for listing. According to the Frost Sullivan report, Emmett is China's largest supplier of hyaluronic acid-based skin fillers by sales in 2021, according to the documents.

7、$Meilan Airport (00357.HK) $Approve the rent waiver policy

Meilan Airport announced that due to the repeated impact of the COVID-19 epidemic, the board of directors reviewed and approved the rent reduction policy today (27). A number of Meilan Airport tenants who meet the relevant requirements can apply for rent remission and / or supplementary waiver for the period from March 1 to April 15 or May 31 this year.

It is expected that the company's income will be reduced by about 64.69 million yuan as a result of the rent reduction policy. The Board is of the view that the rent waiver policy will not have a significant impact on the sustainability and long-term development of the company.

Important matters

Bohai Bank (09668) Capital Operation Center approved to open

Meilan Airport (00357): approval of rent reduction policy

Shanghai Fosun Pharmaceutical (02196) holding subsidiary signs license agreement with Kai Pharma

Clover organism-B (02197): COVID-19 candidate vaccine showed strong cross-neutralizing effect on Omicron as a homologous strengthening needle.

And platinum medicine-B (02142.HK): B7H4X4-1BB bispecific antibody is approved by FDA new drug research in the United States.

China Mengniu Dairy (02319) proposed to privatize Yashili International (01230) has not yet met any preconditions for the plan.

CNOOC Petrochemical (03983) is listed to transfer its 79.98% stake in Dayukou, Hubei Province, with an initial floor price of 1.745 billion yuan.

Chenming Paper (01812) introduces investors to increase the capital of Zhanjiang Chenming by 400 million yuan.

China Software International (00354), Shenkaihong and Qingdao Guochuang signed a strategic cooperation agreement to jointly build a "Smart Home Appliance Software Innovation Center".

China Everbright Water (01857) plans to set up a project company to invest in the PPP project of a sewage treatment plant.

Financial data

Trip.com-S (09961) released results with a net operating income of 4.1 billion yuan in the first quarter, which remained stable compared with the same period last year.

The annual net profit of Oshudan (00973) increased by 57.5% to 242 million euros, with a final interest of 0.06585 euros.

The annual return net profit of Jinshang Machine tool China (01651) increased by 70.28% to 667 million yuan, with a final interest of HK $0.40.

Carrie International's (01050) annual net profit of HK $549 million increased by 23% over the same period last year.

Real Group (06639) announced its annual results, its revenue increased by 7.16% to 1.624 billion yuan, and the number of visits has been increasing steadily.

Listing of new shares

Weilong's income from hearing through HKEx increases to 4.8 billion yuan in 2021.

MINISO Group was heard by the Hong Kong Stock Exchange, with a book cash of up to 5.3 billion.

Amy Express HKEx is the largest supplier of hyaluronic acid-based skin fillers in China.

The main board of Hongkong Stock Exchange is a leading professional manufacturer of chemical and new materials in China.

The price of Tuya Inc.-W (02391) is set at HK $19.30 per share.

Zhongkang Holdings (02361) will issue 75 million shares from June 28th to July 5th.

Repurchase cancellation

AIA Group Limited (01299) spent HK $163 million to buy back 1.98 million shares on June 27th

HSBC Holdings PLC (00005) buys back 1.5964 million shares on the HKEx on June 27th

Weichai Power (02338) spent 63.566 million yuan to buy back 5.04 million A shares on June 27th

Wuxi Apptec (02359) intends to repurchase a total of about 392400 restricted shares. The first restricted A-share repurchase price will be adjusted to 18.17 yuan per share.

China Conch Venture (00586) cancelled a total of 1.995 million shares on June 27th

Stock option

Nofai Health-B (06606) granted 15.0876 million share options to 42 grantees

Debt financing

China ship Leasing (03877) is granted a loan of US $364 million by the bank.

Personnel change

Bai Xin an-B (02185): Yin Jie has resigned as a non-executive director

Jinke Service (09666): Luo Chuansong resigned as Executive Director

Edit / new

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment